MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Exclusion Criteria

• •1. Allergy or significant contraindication to any of the drugs involved in the protocol;
• •2. Patients with concomitant myelofibrosis;
• •3. Severe cardiac disease, including myocardial infarction and cardiac insufficiency;
• •4. Concomitant malignant tumours of other organs;
• •5. Patients with active tuberculosis and HIV-positive patients;
• •6. Other blood system diseases at the same time;
• •7. Pregnant or breastfeeding women;
• •8. Inability to understand or comply with the study protocol;
• •9. Previous intolerance or allergy to similar drugs;
• •10. Concurrent participation in other clinical studies;
• •11. Any other condition that prevents the study from proceeding.